Delayed Facial Nerve Dysfunction Following CyberKnife® Radiosurgery for Vestibular Schwannoma

J. Dixon Johns,Peter H. Ahn,Abdul X. Rashid,Dylan R. Conroy,Paul F. Chisolm,H. Jeffrey Kim
DOI: https://doi.org/10.1002/lary.31627
IF: 2.97
2024-07-06
The Laryngoscope
Abstract:There remains significant variability of reported facial nerve dysfunction rates following stereotactic radiosurgery for the management of vestibular schwannoma. The association between radiation exposure to the vulnerable segments of the facial nerve, including labyrinthine segment, and posttreatment facial nerve dysfunction remains poorly characterized in the literature. This study is the first, to our knowledge, that investigates detailed analysis of radiation doses to the relatively vulnerable labyrinthine segment of the facial nerve with regard to facial nerve dysfunction following Cyberknife® stereotactic radiosurgery. Objective The incidence and risk factors for facial nerve dysfunction (FND) following CyberKnife® therapy for vestibular schwannoma (VS) remain poorly understood. This study investigates whether differential radiation doses to vulnerable segments of the facial nerve may be associated with FND outcomes. Methods Patients were identified who underwent CyberKnife® radiosurgery for VS at a single institution. Basic demographics, tumor characteristics, and facial nerve function were collected. Total radiation doses to tumor, internal auditory canal (IAC), and labyrinthine segment of facial nerve (LSFN) were evaluated. Results Six out of 64 patients experienced FND following CyberKnife® treatment for VS (9.38%, 6/64). Patients with FND were compared to those without FND (control). Of the 64 patients, complete radiation records were obtained for 30 patients (6 FND vs. 24 control). There were no significant differences in demographic or tumor characteristics between control and FND cohorts. More severe FND (HB ≥ 4) had significantly larger tumors (3.74 vs. 1.27 cm3, p = 0.037) with directionally decreased time to FND (3.50 vs. 33.5 months, p = 0.106) than patients with HB
medicine, research & experimental,otorhinolaryngology
What problem does this paper attempt to address?